Berlin, Germany
Vara, founded in 2018, is a pioneering company based in Germany that leverages AI and Machine Learning to enhance the accessibility and effectiveness of breast cancer screening. Their mission, encapsulated by their slogan, "Making data-driven breast cancer screening accessible to everyone; deeptech with a measurable impact backed by evidence," underscores their commitment to universal health care improvements.
The company's innovative software, developed with screening radiologists, reduces human subjectivity in mammography readings, making screenings not only more accurate but also less labor-intensive for physicians. By democratizing access to early screening worldwide, Vara aims to have a significant, evidence-backed impact on global health.
In June 2025, Vara received early VC investment from JR Investment, indicating confidence in their potential for impactful disruption in the healthcare sector. Their approach positions them uniquely at the intersection of AI and Health Care, promising substantial benefits for early cancer detection worldwide.
